Literature DB >> 10785359

Three-dimensional collagen matrices induce delayed but sustained activation of gelatinase A in human endothelial cells via MT1-MMP.

M Nguyen1, J Arkell, C J Jackson.   

Abstract

Gelatinase A, a member of the matrix metalloproteinase (MMP) family, plays an important role during angiogenesis. It is constitutively expressed by human endothelial cells as a latent enzyme and requires activation. Thrombin is the only described physiological inducer of gelatinase A in human endothelial cells. In this study, we investigated the mechanisms of gelatinase A activation by another physiological inducer, collagen. Endothelial cells were cultured on various ECM components for 24 h and the conditioned media were assessed for gelatinase A activity using gelatin zymography. The results demonstrated that type I collagen matrix specifically activates gelatinase A after 24 h in human umbilical vein and 48 h in neonatal foreskin endothelial cells. In contrast, thrombin activated gelatinase A after only 2 h. Activation by collagen was sustained over long periods of time in culture (96 h). Unlike thrombin-induced activation, collagen required active membrane type 1-MMP (MT1-MMP) on the endothelial cell surface to activate gelatinase A. In addition, collagen-induced activation of gelatinase A was inhibited by antibodies to the integrin receptor, alpha(2)beta(1), but not alpha(3)beta(1). Our findings, that collagen can provide long-term activation of gelatinase A are likely to be relevant to endothelial cell invasion during angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10785359     DOI: 10.1016/s1357-2725(00)00013-3

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  8 in total

1.  Combination of thrombin and matrix metalloproteinase-9 exacerbates neurotoxicity in cell culture and intracerebral hemorrhage in mice.

Authors:  Mengzhou Xue; Morley D Hollenberg; V Wee Yong
Journal:  J Neurosci       Date:  2006-10-04       Impact factor: 6.167

Review 2.  Tyrosyl phosphorylated serine-threonine kinase PAK1 is a novel regulator of prolactin-dependent breast cancer cell motility and invasion.

Authors:  Alan Hammer; Maria Diakonova
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

3.  Involvement of metalloprotease-2 in the development of human brain microvessels.

Authors:  Francesco Girolamo; Daniela Virgintino; Mariella Errede; Carmen Capobianco; Nunzia Bernardini; Mirella Bertossi; Luisa Roncali
Journal:  Histochem Cell Biol       Date:  2004-09-15       Impact factor: 4.304

Review 4.  Molecular mediators of angiogenesis.

Authors:  Areck A Ucuzian; Andrew A Gassman; Andrea T East; Howard P Greisler
Journal:  J Burn Care Res       Date:  2010 Jan-Feb       Impact factor: 1.845

Review 5.  Matrix metalloproteinase 14 modulates signal transduction and angiogenesis in the cornea.

Authors:  Jin-Hong Chang; Yu-Hui Huang; Christy M Cunningham; Kyu-Yeon Han; Michael Chang; Motoharu Seiki; Zhongjun Zhou; Dimitri T Azar
Journal:  Surv Ophthalmol       Date:  2015-12-02       Impact factor: 6.048

6.  Therapeutic angiogenesis using basic fibroblast growth factor in combination with a collagen matrix in chronic hindlimb ischemia.

Authors:  Jianyin Zhou; Yilin Zhao; Jinling Wang; Sheng Zhang; Zhengjin Liu; Maochuan Zhen; Yun Liu; Pingguo Liu; Zhenyu Yin; Xiaomin Wang
Journal:  ScientificWorldJournal       Date:  2012-05-15

7.  Three-dimensional matrix fiber alignment modulates cell migration and MT1-MMP utility by spatially and temporally directing protrusions.

Authors:  Stephanie I Fraley; Pei-Hsun Wu; Lijuan He; Yunfeng Feng; Ranjini Krisnamurthy; Gregory D Longmore; Denis Wirtz
Journal:  Sci Rep       Date:  2015-10-01       Impact factor: 4.379

8.  MMP-2 mediates local degradation and remodeling of collagen by annulus fibrosus cells of the intervertebral disc.

Authors:  Anshu Rastogi; Hyunchul Kim; Julianne D Twomey; Adam H Hsieh
Journal:  Arthritis Res Ther       Date:  2013-04-27       Impact factor: 5.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.